Jessica Owens, co-founder of Initiate Ventures and former Grail executive, expressed cautious optimism for life science venture capital despite current market volatility. Speaking at Aspen Ideas: Health, Owens highlighted her transition from science to finance and underscored the long-term potential of biotech innovation. This perspective offers insight into venture capital dynamics shaping funding flows and strategic investments in the biotech sector during uncertain economic periods.